You are here:

Healthcare & Life Sciences

The rapid-changing regulatory environment and the specific needs for protection and commercialization of the key business assets in the healthcare & life sciences sector call for comprehensive advice based on extensive expertise. We have made it our mission to deliver you with inspiring solutions to tackle your challenges and allow your business to thrive.

Our clients range from med-tech and bio-tech companies, all the way to pharmaceutical leaders, investors, suppliers, cure and care institutions, insurers, governmental bodies and healthcare real estate developers.


Full range of services

Our full-service offer integrates a regulatory, legal and tax approach, with a particular focus on:

  • Private and public M&A, including private equity;
  • Equity and debt financing;
  • Joint-ventures and collaborations, including R&D;
  • Protection and commercialization of intellectual property assets;
  • Contracts related to development, manufacturing and distribution of regulated products;
  • Regulatory requirements, authorizations and proceedings;
  • Employment, general corporate governance and restructurings;
  • Swiss and international direct tax and VAT.

Advice beyond borders

Our global dedicated healthcare & life sciences team consists of 40 attorneys at law and tax advisors working together to provide leading expertise across a wide range of disciplines. We bring together expertise in commercial, corporate, tax, regulatory, intellectual property, competition, data protection, and employment matters. Combined with monitoring market developments, this allows us to provide advice in a proactive and pragmatic manner, enabling you to capitalize on business opportunities.

Local knowledge in our home jurisdictions and the EU combined with cross-border expertise: that is what we can offer you to ensure first-class advice.

What you can expect

  • In-depth knowledge of the sector, your business model, and future developments;
  • Creative answers and solutions from a tight-knit team;
  • Pragmatic, clear, concise and well-thought-out advice;
  • Responsive service with short delivery time frames;
  • Competitive fees based on our extensive track record and specialization; and
  • A strong commitment to a mutually beneficial long-term partnership.
sample-deal-air-liquide-EQT
News - 09 April 2020 - Luxembourg

Loyens & Loeff Luxembourg has advised EQT VIII Fund

Loyens & Loeff Luxembourg has advised EQT VIII Fund which has entered into exclusive negotiations to acquire Schülke & Mayr GmbH (“schülke”).
read more
How to structure a joint venture in real estate?
Deal - 03 April 2020 - Switzerland

Loyens & Loeff advised Karo Pharma AB

Loyens & Loeff advised Karo Pharma AB on Swiss aspects of the acquisition of all shares in Hygis SA.
read more
ch-platinum-equity
Deal - 13 March 2019 - Switzerland

Platinum Equity acquires the water care business from Lonza AG

Loyens & Loeff has advised Platinum Equity with the acquisition of the water care business and operations from Lonza AG.
read more
The Belgian ‘Cayman tax’ and its impact on wealth and estate planning in Belgium
Deal - 26 July 2018 - Switzerland

Acquisition of Takeda Chromo by Shanghai Pharmaceuticals

Loyens & Loeff advised Shanghai Pharmaceuticals Holding Co. on the acquisition of Takeda Chromo Beteiligungs AG.
read more
  1. 1
  2. 2
  3. next page